Detalhe da pesquisa
1.
The Dopamine D1 Receptor Positive Allosteric Modulator Mevidalen (LY3154207) Enhances Wakefulness in the Humanized D1 Mouse and in Sleep-Deprived Healthy Male Volunteers.
J Pharmacol Exp Ther
; 380(3): 143-152, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34893551
2.
Patient and Physician Perceptions of Virtual Visits for Parkinson's Disease: A Qualitative Study.
Telemed J E Health
; 24(4): 255-267, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28787250
3.
Telemedicine for Parkinson's Disease: Limited Engagement Between Local Clinicians and Remote Specialists.
Telemed J E Health
; 24(9): 722-724, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29297769
4.
Moving Parkinson care to the home.
Mov Disord
; 31(9): 1258-62, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27501323
5.
National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers.
Telemed J E Health
; 22(7): 590-8, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26886406
6.
Current therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches?
Mov Disord
; 29(11): 1404-13, 2014 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25164707
7.
The past, present, and future of telemedicine for Parkinson's disease.
Mov Disord
; 29(7): 871-83, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24838316
8.
Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor-Positive Allosteric Modulator, in Patients With Parkinson Disease.
Clin Pharmacol Drug Dev
; 11(3): 324-332, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34664427
9.
Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor-Positive Allosteric Modulator (D1PAM), in Healthy Subjects.
Clin Pharmacol Drug Dev
; 10(4): 393-403, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33029934
10.
A U.S. survey of patients with Parkinson's disease: satisfaction with medical care and support groups.
Mov Disord
; 25(13): 2128-35, 2010 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20824736
11.
Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease.
Mov Disord
; 25(11): 1652-9, 2010 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20533449
12.
Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants.
Neurol Clin Pract
; 10(1): 7-14, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32190415
13.
Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study.
Mov Disord
; 24(12): 1763-72, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19562761
14.
Telemedicine for the care of nursing home residents with Parkinson's disease.
Mov Disord
; 24(7): 1073-6, 2009 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19353687
15.
Web-based clinical assessments for Parkinson's disease: reliable and feasible.
Mov Disord
; 27(11): 1466, 2012 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22991090
16.
The promise of telemedicine for chronic neurological disorders: the example of Parkinson's disease.
Lancet Neurol
; 16(7): 541-551, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28566190
17.
Preclinical motor manifestations of Huntington disease.
Handb Clin Neurol
; 144: 93-98, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28947128
18.
Palliative Care in Huntington Disease: Personal Reflections and a Review of the Literature.
Tremor Other Hyperkinet Mov (N Y)
; 7: 454, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28428907
19.
A novel design of a Phase III trial of isradipine in early Parkinson disease (STEADY-PD III).
Ann Clin Transl Neurol
; 4(6): 360-368, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28589163
20.
Multiple Wearable Sensors in Parkinson and Huntington Disease Individuals: A Pilot Study in Clinic and at Home.
Digit Biomark
; 1(1): 52-63, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-32095745